Publications by authors named "Coleen Hall"

Claim this Profile
C
Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study.
Imam Waked, Gamal Esmat, Rabab Fouad, Naglaa Allam, Mohamed Hassany, Coleen Hall

J Med Virol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Hubert H Fernandez, James T Boyd, Victor S C Fung, Mark F Lew, Ramon L Rodriguez, Coleen Hall

Mov Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.
David G Standaert, Ramon L Rodriguez, John T Slevin, Michael Lobatz, Susan Eaton, Coleen Hall

Mov Disord Clin Pract· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
Imam Waked, Gamal Shiha, Roula B Qaqish, Gamal Esmat, Ayman Yosry, Coleen Hall

Lancet Gastroenterol Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
Angelo Antonini, Victor S C Fung, James T Boyd, John T Slevin, Coleen Hall

Mov Disord· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.
John T Slevin, Hubert H Fernandez, Cindy Zadikoff, Coleen Hall, Susan Eaton

J Parkinsons Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.
Gretja Schnell, Rakesh Tripathi, Jill Beyer, Thomas Reisch, Preethi Krishnan, Coleen Hall

Antimicrob Agents Chemother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.
Eric Lawitz, Mihály Makara, Ulus Salih Akarca, Paul J Thuluvath, Liliana Lucia Preotescu, Coleen Hall

Gastroenterology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia.
George M Haig, Yili Pritchett, Andreas Meier, Ahmed A Othman, Coleen Hall

J Alzheimers Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial.
Christophe Hézode, Tarik Asselah, K Rajender Reddy, Tarek Hassanein, Marina Berenguer, Coleen Hall

Lancet· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
Hubert H Fernandez, David G Standaert, Robert A Hauser, Anthony E Lang, Victor S C Fung, Coleen M Hall

Mov Disord· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
Timothy E Wilens, Laura M Gault, Ann Childress, Christopher J Kratochvil, Lindsey Bensman, Coleen M Hall

J Am Acad Child Adolesc Psychiatry· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gulf War veterans' health: medical evaluation of a U.S. cohort.
Seth A Eisen, Han K Kang, Frances M Murphy, Melvin S Blanchard, Domenic J Reda, Coleen Hall

Ann Intern Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis